Anna C F Lewis, Naomi Scheinerman
Calls for public engagement in biotechnology governance are ubiquitous but imprecise, leaving practitioners without actionable guidance and allowing institutions to claim engagement benefits without delivering them. We introduce a precision public engagement framework spanning seven dimensions, making choices explicit, enabling accountability, and closing the gap between engagement and legitimacy.